Influenza vaccination in patients with multiple sclerosis

W. A. Sibley, C. R. Bamford and J. F. Laguna

Vaccination was well tolerated by 93 patients with multiple sclerosis who received a total of 209 doses of influenza vaccine. In one patient, evidence of a new lesion developed after vaccination; the relapse rate was less than would be expected in the natural course of the illness. Toxic and allergic reactions appeared with 7% and 0.5% of the vaccinations, respectively--a rate no higher than that observed in the general population.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Immunization and MS: A summary of published evidence and recommendations
Rutschmann et al.
Neurology 2002;59:1837-1843.
ABSTRACT | FULL TEXT  

Influenza vaccination in MS: Absence of T-cell response against white matter proteins
Moriabadi et al.
Neurology 2001;56:938-943.
ABSTRACT | FULL TEXT  

Vaccinations and the Risk of Relapse in Multiple Sclerosis
Confavreux et al.
NEJM 2001;344:319-326.
ABSTRACT | FULL TEXT